Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOE ε4 polymorphism and early postoperative cognitive dysfunction under different general anesthesia maintenance strategies in older adults
ChiCTR-IPR-15006583Phase 4Not yet recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and sevoflurane in post-operative cognitive decline (POCD) (3 arms), sponsored by Shenzhen People's Hospital. Primary endpoints: Vital sign index, Respiration parameter index and 6 more. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
propofolsevoflurane
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR-IPR-15006583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006583.